Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 18, Number 4—April 2012

Dispatch

Drug Susceptibility of Mycobacterium tuberculosis Beijing Genotype and Association with MDR TB

Jurriaan E.M. de SteenwinkelComments to Author , Marian T. ten Kate, Gerjo J. de Knegt, Kristin Kremer, Rob E. Aarnoutse, Martin J. Boeree, Henri A. Verbrugh, Dick van Soolingen, and Irma A.J.M. Bakker-Woudenberg
Author affiliations: Erasmus University Medical Center, Rotterdam, the Netherlands (J.E.M. de Steenwinkel, M.T. ten Kate, G.J. de Knegt, H.A. Verbrugh, I.A.J.M. Bakker-Woudenberg); National Institute of Public Health and the Environment Center for Infectious Disease Control (RIVM),; Bilthoven, the Netherlands (K. Kremer, D. van Soolingen); World Health Organization Regional Office for Europe, Copenhagen, Denmark (K. Kremer); Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands (R.E. Aarnoutse, M.J. Boeree, D. van Soolingen)

Main Article

Figure 1

Frequency of rifampin (RIF)-resistant mutants in Mycobacterium tuberculosis Beijing and East-African/Indian (EAI) genotype strains (5 strains each) originating from Vietnam. Mutation frequencies were determined in duplicate. Statistical analysis was performed by using an unpaired Mann-Whitney test.

Figure 1. Frequency of rifampin (RIF)-resistant mutants in Mycobacterium tuberculosis Beijing and East-African/Indian (EAI) genotype strains (5 strains each) originating from Vietnam. Mutation frequencies were determined in duplicate. Statistical analysis was performed by using an unpaired Mann-Whitney test.

Main Article

TOP